Bridgebio Oncology Therapeutics, Inc. (BBOT)
8.72
-0.03
(-0.34%)
USD |
NASDAQ |
May 19, 16:00
8.73
+0.01
(+0.11%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Market Cap : 698.53M for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Praxis Precision Medicines, Inc. | 8.938B |
| Bicara Therapeutics, Inc. | 1.316B |
| Amgen, Inc. | 178.60B |
| BioMarin Pharmaceutical, Inc. | 9.627B |
| Gilead Sciences, Inc. | 162.02B |
Market Cap Related Metrics
| Price to Book Value | 1.876 |
| Price | 8.72 |
| Earnings Yield | -6.05K% |